Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2013
12/18/2013CN101657420B Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediate
12/17/2013US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof
12/17/2013US8609713 Pyrrole derivatives and their methods of use
12/17/2013CA2774250C C-linked hydroxamic acid derivatives useful as antibacterial agents
12/12/2013WO2013185116A1 Lipids for therapeutic agent delivery formulations
12/12/2013US20130331411 Compounds and methods for treating diseases mediated by protease activated receptors
12/12/2013US20130331397 Compounds and compositions as trk inhibitors
12/12/2013US20130331387 Heteroaryl derivatives as alpha7 nachr modulators
12/12/2013CA2876148A1 Lipids for therapeutic agent delivery formulations
12/11/2013EP2670744A1 Pyrrole derivatives used as modulators of alpha7 nachr
12/11/2013CN203329730U Oil bath type reactor for preparing n-methyl pyrrolidone (NMP)
12/11/2013CN1956952B Histamine H3 receptor agents, preparation and therapeutic uses
12/11/2013CN103443092A Pyrrole derivatives used as modulators of alpha7 nachr
12/11/2013CN103443077A Trpm8受体拮抗剂 Trpm8 receptor antagonist
12/11/2013CN103443075A Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
12/11/2013CN103443074A Heterocyclic amine derivatives
12/11/2013CN103443067A Method for producing 2,2-difluoroethylamine starting from 2,2-difluoro-1-chloroethane
12/11/2013CN103435553A Piperazine structure-based aryl formamide Raf kinase inhibitor and preparation method as well as application thereof
12/11/2013CN103435527A Preparation method of non-steroid anti-inflammatory drug tolmetin
12/11/2013CN103435526A Synthesis method of vildagliptin
12/11/2013CN103435448A High-stereoselectivity method for reducing alkynylamines
12/10/2013US8604071 Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
12/10/2013US8603646 Pyrrole compound and organic photoelectric device including the same
12/10/2013CA2608957C Pyrrolidine derivative or salt thereof
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/05/2013WO2013181451A1 Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarate
12/05/2013WO2013179300A2 A process for the preparation of vildagliptin and its intermediate thereof
12/05/2013WO2013178570A1 Substituted pyrrolidine-2-carboxamides
12/05/2013WO2013148965A3 N-acyl-amino acid derivatives as food flavouring compounds
12/05/2013WO2013132352A3 Covalent functionalization of carbon nanotubes grown on a surface
12/05/2013US20130324687 Compounds, monomers, and polymers containing a carbonate linkage
12/05/2013US20130324556 Protease Activated Receptor 2 (PAR2) Antagonists
12/05/2013US20130324540 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents
12/05/2013US20130324539 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
12/05/2013US20130324531 Substituted pyrrolidine-2-carboxamides
12/05/2013US20130324514 Indanyloxyphenylcyclopropanecarboxylic acids
12/04/2013EP2668160A1 Trpm8 receptor antagonists
12/04/2013EP2668158A1 Method for producing 1-h-pyrrolidine-2,4-dione derivatives
12/04/2013EP2668157A1 Protease activated receptor 2 (par2) antagonists
12/04/2013EP2668151A1 Method for producing 2,2-difluoroethylamine starting from 2,2-difluoro-1-chloroethane
12/04/2013EP2667873A1 Small molecule rnase inhibitors and methods of use
12/04/2013EP2667872A2 Small molecule rnase inhibitors and methods of use
12/04/2013EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/04/2013CN103420981A Substituted-pyrrolidinyl-contained thiomorpholine compounds
12/04/2013CN103420891A Triphosgene method for synthesizing benzene sulphanilamide, intermediate of glimepiride, drug for Type ii Diabetes Mellitus
12/04/2013CN103420890A 3-pyrrole carboxylic acid derivatives, and preparing method and application thereof
12/04/2013CN103420889A Synthetic processing method of 2-benzoyl pyrrole
12/04/2013CN103420888A Preparation method of L-pyroglutamic acid menthyl acetate
12/04/2013CN103420887A Levosulpiride compound and preparation method thereof
12/04/2013CN101646664B Furanone compounds
12/04/2013CN101532996B Method for analyzing and separating levetiracetam by using HPLC method
12/04/2013CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels
12/03/2013US8598078 Condensed anthran I lami de derivatives as insecticides
12/03/2013US8597706 Method for synthesizing 2-acetyl-1-pyrroline, stable ketal precursors thereof, and isotopically marked analogs
12/03/2013CA2599411C Enzyme inhibitors
12/03/2013CA2530302C Novel aminobenzophenone compounds
12/03/2013CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/2013
11/28/2013WO2013177269A2 Zirconium-containing precursors for vapor deposition
11/28/2013WO2013177224A1 N-substituted benzamides and their use in the treatment of pain
11/28/2013WO2013175053A1 Catechol o-methyltransferase activity inhibiting compounds
11/28/2013WO2013174485A1 SUBSTITUTED ß-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS
11/28/2013US20130317223 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
11/28/2013US20130317074 Topical antifungal agent
11/28/2013US20130317013 Ep4 receptor agonist, compositions and methods thereof
11/28/2013US20130317000 N-substituted benzamides and methods of use thereof
11/28/2013US20130316248 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
11/27/2013EP2666769A1 Substituted B-amino acid derivatives as CXCR3 receptor antagonist
11/27/2013EP2665718A2 Improved process for preparation of high molecular weight molybdenum succinimide complexes
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013EP2665705A2 Improved process for preparation of low molecular weight molybdenum succinimide complexes
11/27/2013CN203303708U Filtering equipment for producing panipenem side chain
11/27/2013CN103415504A 2-acyloxy-pyrrolin-4-ones
11/27/2013CN103408481A Method for synthesizing substituted pyrrole-3-formate compound by virtue of microwave radiation in one step
11/27/2013CN103408480A 4-phenyl-pyrrolidone synthesis process
11/27/2013CN102757370B Derivatives of p-aminobenzoic acid and applications thereof
11/27/2013CN102753522B Substituted pyrrolidine-2-carboxamides
11/27/2013CN102617391B Resveratrol benzene acrylamide derivative, preparing method and application thereof
11/27/2013CN102452969B Doripenem side-chain compound and preparation method and application thereof
11/27/2013CN102391168B Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
11/26/2013US8592453 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
11/26/2013US8592419 Ceramides and apoptosis-signaling ligand
11/21/2013WO2013173392A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013WO2013171694A1 Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists
11/21/2013WO2013171687A1 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists
11/21/2013WO2013171484A1 Crystallisation process
11/21/2013US20130310559 Isoprenyl compounds and methods thereof
11/21/2013US20130310558 Synthesis, structure and use of functionalized naphthalenes
11/21/2013US20130310555 Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
11/21/2013US20130310423 Diterpenoid derivatives endowed of biological properties
11/21/2013US20130310419 Pyrrole derivatives used as modulators of alpha7 nachr
11/21/2013US20130310379 Modulators of methyl modifying enzymes, compositions and uses thereof
11/21/2013US20130310377 Novel modulators of calcium release-activated calcium channel
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
11/20/2013EP2663548A1 Pegylated lipids and their use for drug delivery
11/20/2013EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/20/2013EP2240443B1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain
11/20/2013EP1540037B1 Organic salts and their use as reagents in electrochemical reactions
11/20/2013CN203295400U Glimepiride intermediate purifying device
11/20/2013CN103403582A Curable coloring composition, color filter and manufacturing method for same, liquid crystal display device, solid-state image-capturing device, and dye compound.
11/20/2013CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 404